ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Board Review Course & Update

Schedule is subject to change. Final Schedule will be posted in May 2021. Download preliminary schedule »

Saturday, July 17

Assessment of Kidney Function and Structure

Time Session Details

Urinalysis/Urine Microscopy Cases

  • Mark A. Perazella, MD, FASN

Imaging Cases in Nephrology

  • Mark A. Perazella, MD, FASN

Case Discussions: Onco-Nephrology

  • Mark A. Perazella, MD, FASN
  • Mitchell H. Rosner, MD, FASN

Approach to the Interpretation of Proteinuria, Albuminuria, Hematuria, and Urinary Sediment

  • Richard J. Glassock, MD, FASN

Acute and Chronic Interstitial Nephritis

  • Mark A. Perazella, MD, FASN


Perturbations in the Distribution of the Body Fluid Compartments and Fluid and Electrolyte Disorders

Time Session Details

Relationship Between Sodium and Water: Principles of Hyponatremia and Hypernatremia

  • Mitchell H. Rosner, MD, FASN

Nephrotoxins for the Boards

  • Mark A. Perazella, MD, FASN

Inherited Renal Cystic Diseases

  • Ronald D. Perrone, MD, FASN

Estimating GFR: From Physiology to Public Health

  • Cynthia Delgado, MD, FASN

Case Discussions: Volume, Sodium, and Water Disorders

  • Roger A. Rodby, MD, FASN
  • Mitchell H. Rosner, MD, FASN

Add Efficiency to Your Studying: Change the Way You Approach the Boards

  • Laura J. Maursetter, DO, FASN


Back to top

Sunday, July 18

Glomerular and Vascular Disorders - Part 1

Time Session Details

Viral Nephritides, Including HIV, CMV and Hepatitis

  • Nelson Leung, MD

Secondary Glomerulonephritides and Vasculitis

  • Ronald J. Falk, MD, FASN

Pathology of Glomerulonephritides

  • Glen S. Markowitz, MD

Pathogenesis and Mechanisms of Glomerular Injury

  • Patrick H. Nachman, MD, FASN

IgA Nephrology and Cases

  • Patrick H. Nachman, MD, FASN

Idiopathic and Primary Glomerulonephritides

  • Laura H. Mariani, MD, MS

Diabetic Nephropathy

  • William Luke Whittier, MD, FASN


Glomerular and Vascular Disorders - Part 2

Time Session Details

Dysproteinemias, Amyloid, Fibrillary Glomerulonephritis, and Thrombotic Angiopathies

  • Nelson Leung, MD

Diabetic Kidney Disease Cases

  • Roger A. Rodby, MD, FASN

Case Discussions: Glomerulonephritides - II

  • Ronald J. Falk, MD, FASN
  • Nelson Leung, MD
  • Laura H. Mariani, MD, MS
  • Glen S. Markowitz, MD
  • Patrick H. Nachman, MD, FASN

Case Discussions: Glomerulonephritides - I

  • Ronald J. Falk, MD, FASN
  • Nelson Leung, MD
  • Laura H. Mariani, MD, MS
  • Glen S. Markowitz, MD
  • Patrick H. Nachman, MD, FASN


Back to top

Monday, July 19

Tubulointerstitial Disorders and Nephrolithiasis

Time Session Details

Pregnancy and Kidney Disease

  • Belinda Jim, MD

Nephrolithiasis: Pathogenesis, Diagnosis, and Medical Management

  • David S. Goldfarb, MD, FASN

Nephrolithiasis: Challenging Cases

  • David S. Goldfarb, MD, FASN

Genetic Renal Disease

  • Barry I. Freedman, MD

Case Discussions: Genetics and Pregnancy

  • Barry I. Freedman, MD
  • Belinda Jim, MD


Potassium and Acid Base

Time Session Details

Potassium: Hypokalemic and Hyperkalemic Disorders

  • Biff F. Palmer, MD, FASN

Poisonings and Intoxications

  • David S. Goldfarb, MD, FASN

Normal Kidney Potassium Handling

  • Biff F. Palmer, MD, FASN

Non-Anion Gap Acidosis

  • Susie L. Hu, MD, FASN

Metabolic Alkalosis

  • Susie L. Hu, MD, FASN

Increased Anion Gap Metabolic Acidosis

  • Biff F. Palmer, MD, FASN

Case Discussions: Acid Base

  • Biff F. Palmer, MD, FASN
  • Roger A. Rodby, MD, FASN

Acid-Base Disorders: Key Core Concepts

  • Kalani L. Raphael, MD, MS, FASN


Back to top

Tuesday, July 20

CKD and ESKD - Part 1

Time Session Details

Principles of Drug Prescribing in Acute and Chronic Kidney Diseases

  • William M. Bennett, MD, FASN

How Dialysis Works: Physics/Physiology of Dialysis: The Basics, Similarities, and Differences Between PD and HD

  • Sana Waheed, MD, FASN

ESKD Vascular Access and Related Infections

  • Monnie Wasse, MD, MPH, FASN

ESKD Cases

  • Christopher T. Chan, MD

Dialysis: Prescription and Adequacy Issues for HD and PD

  • Suzanne Watnick, MD, FASN

Dialysis: Cardiovascular and Blood Pressure Issues

  • Susan Hedayati, MD, MS, FASN

Common Medical Problems in the Patient with ESKD

  • Mark L. Unruh, MD, MS

CKD Cases

  • Christopher T. Chan, MD

Anemia and Metabolic Acidosis in CKD and ESKD

  • Susan Hedayati, MD, MS, FASN


CKD and ESKD - Part 2

Time Session Details

Peritoneal Dialysis: Infectious and Non-Infectious Complications

  • Suzanne Watnick, MD, FASN

Hemodialysis: Selected Complications

  • Mark L. Unruh, MD, MS

Board Review Cases

  • Laura J. Maursetter, DO, FASN
  • Roger A. Rodby, MD, FASN


Back to top

Wednesday, July 21

AKI, ICU Nephrology, and Pharmacology - Part 1

Time Session Details

Secondary Hypertension: Clinical Syndromes, Diagnostic Workup, and Management

  • George L. Bakris, MA, MD, FASN

Renal Artery Stenosis, Renovascular Hypertension, and Ischemic Nephropathy

  • Stephen C. Textor, MD

Pathophysiology and Treatment: Essential Hypertension

  • Stephen C. Textor, MD

Hypertensive Urgencies and Emergencies: Clinical Presentations and Therapy

  • Tara I. Chang, MD, MS, FASN

Drug-Induced Hypertension

  • Tara I. Chang, MD, MS, FASN

Case Discussions: Hypertension

  • George L. Bakris, MA, MD, FASN
  • Tara I. Chang, MD, MS, FASN
  • Stephen C. Textor, MD


AKI, ICU Nephrology and Pharmacology - Part 2

Time Session Details

Case Discussions: AKI and ICU Nephrology

  • Jay L. Koyner, MD
  • Ashita J. Tolwani, MD, MS

AKI: Prevention and Non-Dialytic Therapy

  • Jay L. Koyner, MD

AKI: Pathogenesis, Diagnosis, Biomarkers, and Risk Assessment

  • Jay L. Koyner, MD

Acute Renal Replacement Therapies

  • Ashita J. Tolwani, MD, MS


Back to top

Thursday, July 22

Bone and Mineral Metabolism

Time Session Details

Treatment of CKD-MBD

  • Tamara Isakova, MD

Magnesium: Normal Physiology, Hypomagnesemia, and Hypermagnesemia

  • Laura J. Maursetter, DO, FASN

Case Discussions: Metabolic Bone Diseases

  • Tamara Isakova, MD
  • Myles Wolf, MD

Calcium/Phosphorous/PTH, Vitamin D, and FGF-23: Pathophysiology of Metabolic Bone Disease

  • Myles Wolf, MD


Transplantation

Time Session Details

Transplant Immunology

  • Michelle A. Josephson, MD, FASN

Transplant Evaluation

  • Michelle A. Josephson, MD, FASN

Transplant Cases

  • William M. Bennett, MD, FASN
  • Michelle A. Josephson, MD, FASN

Transplant Biopsy: Indications and Findings

  • Jean Hou, MD

Post-Transplant Non-Infectious Complications

  • Michelle A. Josephson, MD, FASN

Post-Transplant Infectious Complications

  • Michael G. Ison, MD, MS

Board Review Cases 2

  • Laura J. Maursetter, DO, FASN


Back to top